The total number of records retrieved from this search are 16. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_4571	Virus nameAdenovirus	Virus strainCD55-TRAIL+ CD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIl and MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4572	Virus nameAdenovirus	Virus strainCD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4573	Virus nameAdenovirus	Virus strainCD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4574	Virus nameAdenovirus	Virus strainCD55-TRAIL-IETD-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4575	Virus nameAdenovirus	Virus strainCD55-TRAIL+ CD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIl and MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cancer cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4576	Virus nameAdenovirus	Virus strainCD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cancer cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4577	Virus nameAdenovirus	Virus strainCD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result82% cancer cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4578	Virus nameAdenovirus	Virus strainCD55-TRAIL-IETD-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result72% cancer cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4579	Virus nameAdenovirus	Virus strainCD55-TRAIL+ CD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIl and MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result70% cancer cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4580	Virus nameAdenovirus	Virus strainCD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result70% cancer cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4581	Virus nameAdenovirus	Virus strainCD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result62% cancer cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4582	Virus nameAdenovirus	Virus strainCD55-TRAIL-IETD-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result50% cancer cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4583	Virus nameAdenovirus	Virus strainCD55-TRAIL+ CD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIl and MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result60% cancer cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4584	Virus nameAdenovirus	Virus strainCD55-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing MnSOD gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result60% cancer cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4585	Virus nameAdenovirus	Virus strainCD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationvirus containing TRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result58% cancer cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225
IDOV_4586	Virus nameAdenovirus	Virus strainCD55-TRAIL-IETD-MnSOD	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman lung carcinoma cell line	Cell lineNCI-H1299	Concentration of cell line5.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result42% cancer cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis	Immunogenic effectNA	Clinical trialNA	PMID27080225